Single-cell dissection of remodeled inflammatory ecosystem in primary and metastatic gallbladder carcinoma.
Wang X, Liu C, Chen J, Chen L, Ren X, Hou M, Cui X, Jiang Y, Liu E, Zong Y, Duan A, Fu X, Yu W, Zhao X, Yang Z, Zhang Y, Fu J, Wang H.
Cell Discov. 2022 Oct 5;8(1):101. doi: 10.1038/s41421-022-00445-8.
Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells.
Wang Z, Li W, Wang X, Zhu Q, Liu L, Qiu S, Zou L, Liu K, Li G, Miao H, Yang Y, Jiang C, Liu Y, Shao R, Wang X, Liu Y.
Chin Med J (Engl). 2023 Sep 20;136(18):2210-2220. doi: 10.1097/CM9.0000000000002675. Epub 2023 Jul 24.
Reappraisal of T1b gallbladder cancer (GBC): clinicopathologic analysis of 473 in situ and invasive GBCs and critical review of the literature highlights its rarity, and that it has a very good prognosis.
Pehlivanoglu B, Akkas G, Memis B, Basturk O, Reid MD, Saka B, Dursun N, Bagci P, Balci S, Sarmiento J, Maithel SK, Bandyopadhyay S, Escalona OT, Araya JC, Losada H, Goodman M, Knight JH, Roa JC, Adsay V.
Virchows Arch. 2023 Feb;482(2):311-323. doi: 10.1007/s00428-022-03482-6. Epub 2022 Dec 29.
LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, Xiang SS, Song XL, Jiang L, Zhang YJ, Huang W, Chen SL, Liu FT, Chen C, Zhu Q, Chen HZ, Shao R, Liu YB.
Mol Cancer. 2019 Nov 21;18(1):167. doi: 10.1186/s12943-019-1097-9.
Investigation of targetable predictive and prognostic markers in gallbladder carcinoma.
Neyaz A, Husain N, Gupta S, Kumari S, Arora A, Awasthi NP, Malhotra KP, Misra S.
J Gastrointest Oncol. 2018 Feb;9(1):111-125. doi: 10.21037/jgo.2017.10.02.
Global epidemiological trends and variations in the burden of gallbladder cancer.
Vuthaluru S, Sharma P, Chowdhury S, Are C.
J Surg Oncol. 2023 Nov;128(6):980-988. doi: 10.1002/jso.27450.
ISH-based HER2 diagnostics.
Rüschoff J, Nagelmeier I, Jasani B, Stoss O.
Pathologe. 2021 Nov;42(Suppl 1):62-68. doi: 10.1007/s00292-020-00878-6. Epub 2020 Dec 21.
Carcinoma in situ of the gallbladder. A clinicopathologic study of 18 cases.
Albores-Saavedra J, de Jesus Manrique J, Angeles-Angeles A, Henson DE.
Am J Surg Pathol. 1984 May;8(5):323-33. doi: 10.1097/00000478-198405000-00001.
The Undertreatment of Gallbladder Cancer: Gaps in Seeking, Reaching, and Receiving Care.
Keilson JM, Maithel SK.
Ann Surg Oncol. 2021 Jun;28(6):2925-2927. doi: 10.1245/s10434-021-09761-x. Epub 2021 Mar 4.
The optimal extent of surgery in T2 gallbladder cancer and the need for hepatectomy: A meta-analysis.
Burasakarn P, Thienhiran A, Hongjinda S, Fuengfoo P.
Asian J Surg. 2022 Jan;45(1):33-38. doi: 10.1016/j.asjsur.2021.05.005. Epub 2021 May 26.
